BioGram ApS: Financial statements 2023
CVR: 40922598
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioGram ApS (CVR 40922598) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 371,054 and a net result of DKK 282,830 compared with DKK 102,704 the year before. That is an increase of 616.5% compared with the year before. Equity in the 2023 report amounted to DKK 435,970. The solvency ratio was 61.1%.
- Gross Profit
- DKK 371,054
- Profit/Loss
- DKK 282,830
- Equity
- DKK 435,970
- Total Assets
- DKK 713,856
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 371 t. | 283 t. | 436 t. | - |
| 2022 | - | 52 t. | 103 t. | 256 t. | - |
| 2021 | - | 233 t. | 182 t. | 452 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioGram ApS has published its annual report for 2022. Gross profit came to DKK 51,785, and the net result was DKK 102,704.
About BioGram ApS
BioGram ApS is a Danish company of the type Anpartsselskab based in Ølstykke, founded in 2019. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Per Gram. The company is owned by BioGram Holding ApS. In 2025, the company reported a gross profit of DKK 287,937 and a net result of DKK 222,179 compared with DKK 170,237 the year before. Equity in the 2025 report amounted to DKK 127,799.